Betoptic 5 mg/ml øjendråber, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

betoptic 5 mg/ml øjendråber, opløsning

novartis healthcare a/s - betaxololhydrochlorid - øjendråber, opløsning - 5 mg/ml

Betoptic S 2,5 mg/ml øjendråber, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

betoptic s 2,5 mg/ml øjendråber, suspension

immedica pharma ab - betaxololhydrochlorid - øjendråber, suspension - 2,5 mg/ml

Orap 1 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orap 1 mg tabletter

eumedica pharmaceuticals gmbh - pimozid - tabletter - 1 mg

Orap 1 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orap 1 mg tabletter

2care4 aps - pimozid - tabletter - 1 mg

Orap 4 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orap 4 mg tabletter

eumedica pharmaceuticals gmbh - pimozid - tabletter - 4 mg

Stromolol 2,5 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

stromolol 2,5 mg filmovertrukne tabletter

aristo pharma gmbh - bisoprololfumarat - filmovertrukne tabletter - 2,5 mg

Symbicort 4,5+160 mikrog/dosis inhalationsspray, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

symbicort 4,5+160 mikrog/dosis inhalationsspray, suspension

astrazeneca a/s - budesonid, formoterolfumarat dihydrat - inhalationsspray, suspension - 4,5+160 mikrog/dosis

Symbicort 4,5+160 mikrog/dosis inhalationsspray, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

symbicort 4,5+160 mikrog/dosis inhalationsspray, suspension

paranova danmark a/s - budesonid, formoterolfumarat dihydrat - inhalationsspray, suspension - 4,5+160 mikrog/dosis

BiResp Spiromax Den Europæiske Union - dansk - EMA (European Medicines Agency)

biresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Brintellix Den Europæiske Union - dansk - EMA (European Medicines Agency)

brintellix

h. lundbeck a/s - vortioxetine - depressiv lidelse, major - psychoanaleptics, - behandling af alvorlige depressive episoder hos voksne.